Susquehanna International Group
GEVA

Susquehanna International Group’s SYNAGEVA BIOPHARMA CORP COM STK (DE) GEVA Stock Holding History

Susquehanna International Group’s Portfolio GEVA Stock Details GEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-26,300
Closed -$2.56M – 10811
2015
Q1 		$2.56M Sell
26,300
-2,500
-9% -$265K ﹤0.01% 3830
2014
Q4 		$2.67M Sell
28,800
-27,400
-49% -$2.16M ﹤0.01% 3925
2014
Q3 		$3.87M Sell
56,200
-130,200
-70% -$9.32M ﹤0.01% 3429
2014
Q2 		$19.5M Buy
186,400
+58,900
+46% +$5.01M 0.01% 1426
2014
Q1 		$10.6M Buy
127,500
+106,200
+499% +$9.82M ﹤0.01% 1954
2013
Q4 		$1.38M Sell
21,300
-20,400
-49% -$1.21M ﹤0.01% 4921
2013
Q3 		$2.64M Buy
+41,700
New +$2.05M ﹤0.01% 3672

Susquehanna International Group's GEVA Position: Q2 2015 in Review

Susquehanna International Group sold out of SYNAGEVA BIOPHARMA CORP COM STK (DE) (GEVA) in Q2 2015, closing a stake of 6,944 shares — an estimated $677K sold.

Susquehanna International Group first reported a position in GEVA in Q2 2013 and held it in 8 quarters. The position peaked at $1.9M in Q4 2013. 0 funds tracked by Wall St. Rank hold GEVA as of Q2 2015.

  • Susquehanna International Group reported no remaining SYNAGEVA BIOPHARMA CORP COM STK (DE) position as of Q2 2015 after selling out during the quarter.
  • Susquehanna International Group sold 6,944 SYNAGEVA BIOPHARMA CORP COM STK (DE) shares in Q2 2015, an estimated $677K.
  • Susquehanna International Group first reported a position in SYNAGEVA BIOPHARMA CORP COM STK (DE) in Q2 2013 and held it in 8 quarters.
  • Susquehanna International Group's SYNAGEVA BIOPHARMA CORP COM STK (DE) position peaked at $1.9M in Q4 2013.
  • 0 funds tracked by Wall St. Rank held SYNAGEVA BIOPHARMA CORP COM STK (DE) as of Q2 2015.

Based on Susquehanna International Group's 13F filing for Q2 2015, filed 14 Aug 2015.